C16 Glucosyl(β) Ceramide (d18:1/16:0)
| Catalog Number | BL-M000993 |
| CAS Number | 74365-77-8 |
| Description | C16 Glucosyl(β) Ceramide (d18:1/16:0) is a crucial lipid molecule that belongs to the ceramide family. It exerts profound effects on cellular signaling cascades and lipid homeostasis. Its intricate involvement in the pathophysiology of various conditions such as cancer and neurodegenerative ailments highlights its significance as a promising therapeutic target for drug innovation in these pathological contexts. |
 | |
| IUPAC Name | N-[(E,2S,3R)-3-hydroxy-1-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadec-4-en-2-yl]hexadecanamide |
| Synonyms | D-glucosyl-β-1,1'-N-palmitoyl-D-erythro-sphingosine; C16 β-D-glucosyl ceramide; N-(hexadecanoyl)-1-β-glucosyl-sphing-4-enine; Glucosylceramide (d18:1/16:0); beta-D-glucosyl-N-hexadecanoylsphingosine |
| Molecular Weight | 700.04 |
| Molecular Formula | C40H77NO8 |
| Boiling Point | 842.8±65.0 °C at 760 mmHg |
| Purity | >99% |
| Density | 1.1±0.1 g/cm3 |
| Appearance | Powder |
| Shelf Life | 1 Year |
| Storage | Store at -20°C |
| Percent Composition | C 68.63%, H 11.09%, N 2.00%, O 18.28% |
| Canonical SMILES | CCCCCCCCCCCCCCCC(=O)NC(COC1C(C(C(C(O1)CO)O)O)O)C(C=CCCCCCCCCCCCCC)O |
| InChI | InChI=1S/C40H77NO8/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-34(43)33(32-48-40-39(47)38(46)37(45)35(31-42)49-40)41-36(44)30-28-26-24-22-20-18-16-14-12-10-8-6-4-2/h27,29,33-35,37-40,42-43,45-47H,3-26,28,30-32H2,1-2H3,(H,41,44)/b29-27+/t33-,34+,35+,37+,38-,39+,40+/m0/s1 |
| InChI Key | VJLLLMIZEJJZTE-NNTBDIJYSA-N |
※ Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Related Products
Online Inquiry
